Serum Vascular Endothelial Growth Factor (VEGF) and Microvessel Tumor Invasion in Hepatocellular Carcinomas.
- Author:
Seong Woo HONG
1
;
Dong Hee WHANG
;
In Wook PAIK
;
Hyuck Sang LEE
Author Information
1. Department of Surgery, Inje University, Seoul Paik Hospital, Seoul, Korea. lib0196@thrunet.com
- Publication Type:Original Article
- Keywords:
Vascular endothelial growth factor;
Hepatocellular carcinoma;
Microvessel tumor invasion
- MeSH:
Angiogenesis Inducing Agents;
Carcinoma, Hepatocellular*;
Enzyme-Linked Immunosorbent Assay;
Humans;
Microvessels*;
Vascular Endothelial Growth Factor A*
- From:Journal of the Korean Surgical Society
2003;64(3):224-228
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Vascular endothelial growth factor (VEGF) is a potent angiogenic factor in a number of cancers. The aim of this study was to evaluate the clinical significance of the serum level of VEGF in hepatocellular carcinoma (HCC) patients. METHODS: Serum VEGF was measured by an enzyme linked immunosorbent assay (ELISA) method. The correlation between serum VEGF level and clinico-pathological data of HCC patients were evaluated. RESULTS: The serum VEGF levels significantly increased with increasing tumor size and platelets count. The mean serum VEGF level in HCC patients with microvessel tumor invasion was higher than in those without microvessel tumor invasion. CONCLUSION: A high serum VEGF level may be an indicator of tumor progression and an important predictor of microvessel tumor invasion.
